Rendering

Component: (Network and Table)
Network
2416405 - Disclosure - Condensed consolidating financial information - Condensed Consolidating Statement of Operations (Detail)
(http://www.express-scripts.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementOfOperationsDetail)
TableCondensed Financial Statements [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001532063 (http://www.sec.gov/CIK)
Condensed Financial Statements, Captions [Line Items]Period [Axis]
2013-10-01 - 2013-12-31
2013-07-01 - 2013-09-30
2013-04-01 - 2013-06-30
2013-01-01 - 2013-12-31
2013-01-01 - 2013-03-31
2012-10-01 - 2012-12-31
2012-07-01 - 2012-09-30
2012-04-01 - 2012-06-30
2012-01-01 - 2012-12-31
2012-01-01 - 2012-03-31
2011-01-01 - 2011-12-31
Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]Consolidation Items [Axis]
Consolidation Items [Domain]Consolidation Items [Domain]Consolidation Items [Domain]Consolidation, Eliminations [Member]Consolidation Items [Domain]Consolidation Items [Domain]Consolidation Items [Domain]Consolidation Items [Domain]Consolidation Items [Domain]Consolidation, Eliminations [Member]Consolidation Items [Domain]Consolidation Items [Domain]Consolidation, Eliminations [Member]Consolidation Items [Domain]
Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]Legal Entity [Axis]
Entity [Domain]Entity [Domain]Entity [Domain]Entity [Domain]Parent Company [Member]Subsidiaries [Member]Medco Health Solutions Inc [Member]Guarantor Subsidiaries [Member]Non-Guarantor Subsidiaries [Member]Entity [Domain]Entity [Domain]Entity [Domain]Entity [Domain]Entity [Domain]Entity [Domain]Parent Company [Member]Subsidiaries [Member]Medco Health Solutions Inc [Member]Guarantor Subsidiaries [Member]Non-Guarantor Subsidiaries [Member]Entity [Domain]Entity [Domain]Entity [Domain]Parent Company [Member]Subsidiaries [Member]Medco Health Solutions Inc [Member]Guarantor Subsidiaries [Member]Non-Guarantor Subsidiaries [Member]Entity [Domain]
Revenues
25,781,400,000 2,3
25,915,600,000 2,3
26,381,900,000 2,3
(3,357,400,000) 
0  
29,927,900,000  
52,736,800,000  
23,273,800,000  
1,517,700,000  
104,098,800,000 1
26,019,900,000 2,3
27,365,100,000 2,3
26,761,600,000 2,3
27,455,000,000 2,4,3
(2,472,100,000) 
0  
29,763,100,000  
43,085,700,000  
22,007,800,000  
1,329,800,000  
93,714,300,000 1
12,132,600,000 2,4,3
0  
0  
29,450,900,000  
0  
16,520,300,000  
157,100,000  
46,128,300,000 1
Operating expenses
 
 
 
(3,357,400,000) 
0  
28,380,500,000  
52,498,300,000  
21,988,000,000  
1,037,700,000  
100,547,100,000  
 
 
 
 
(2,472,100,000) 
0  
28,591,800,000  
43,090,300,000  
20,573,700,000  
1,136,700,000  
90,920,400,000  
 
0  
0  
27,847,900,000  
0  
15,841,300,000  
124,700,000  
43,813,900,000  
Operating income
828,800,000 3
875,500,000 3
1,004,300,000 3
0  
0  
1,547,400,000  
238,500,000  
1,285,800,000  
480,000,000  
3,551,700,000  
843,100,000 3
906,900,000 3
820,700,000 3
499,400,000 4,3
0  
0  
1,171,300,000  
(4,600,000) 
1,434,100,000  
193,100,000  
2,793,900,000  
566,900,000 4,3
0  
0  
1,603,000,000  
0  
679,000,000  
32,400,000  
2,314,400,000  
Total other (expense) income
 
 
 
0  
(343,900,000) 
(148,800,000) 
(23,500,000) 
5,400,000  
(10,600,000) 
(521,400,000) 
 
 
 
 
0  
(373,700,000) 
(180,100,000) 
(49,400,000) 
(2,200,000) 
11,900,000  
(593,500,000) 
 
0  
(22,200,000) 
(259,800,000) 
0  
(5,900,000) 
600,000  
(287,300,000) 
Income before taxes
 
 
 
0  
(343,900,000) 
1,398,600,000  
215,000,000  
1,291,200,000  
469,400,000  
3,030,300,000  
 
 
 
 
0  
(373,700,000) 
991,200,000  
(54,000,000) 
1,431,900,000  
205,000,000  
2,200,400,000  
 
0  
(22,200,000) 
1,343,200,000  
0  
673,100,000  
33,000,000  
2,027,100,000  
Provision for income taxes
 
 
 
0  
(124,800,000) 
533,000,000  
93,300,000  
470,600,000  
131,900,000  
1,104,000,000  
 
 
 
 
0  
(142,100,000) 
449,600,000  
(20,400,000) 
550,800,000  
100,000  
838,000,000  
 
0  
(8,100,000) 
487,900,000  
0  
263,800,000  
5,000,000  
748,600,000  
Net income (loss) from continuing operations
518,300,000 3
453,600,000 3
574,400,000 3
0  
(219,100,000) 
865,600,000  
121,700,000  
820,600,000  
337,500,000  
1,926,300,000  
380,000,000 3
524,100,000 3
415,900,000 3
152,200,000 4,3
0  
(231,600,000) 
541,600,000  
(33,600,000) 
881,100,000  
204,900,000  
1,362,400,000  
270,200,000 4,3
0  
(14,100,000) 
855,300,000  
0  
409,300,000  
28,000,000  
1,278,500,000  
Net loss from discontinued operations, net of tax
(12,300,000)3
(15,500,000)3
(23,900,000)3
0  
0  
0  
0  
0  
(53,600,000) 
(53,600,000) 
(1,900,000)3
(13,100,000)3
(20,000,000)3
800,000 4,3
0  
0  
0  
0  
0  
(32,300,000) 
(32,300,000) 
0 4,3
 
 
 
 
 
 
0  
Equity in earnings of subsidiaries
 
 
 
(3,140,100,000) 
2,063,700,000  
803,500,000  
272,900,000  
0  
0  
0  
 
 
 
 
(2,581,000,000) 
1,544,500,000  
740,000,000  
296,500,000  
0  
0  
0  
 
(1,724,500,000) 
1,289,900,000  
434,600,000  
0  
0  
0  
0  
Net income
506,000,000 3
 
438,100,000 3
 
550,500,000 3
 
(3,140,100,000) 
 
1,844,600,000  
 
1,669,100,000  
 
394,600,000  
 
820,600,000  
 
283,900,000  
 
1,872,700,000  
 
378,100,000 3
 
511,000,000 3
 
395,900,000 3
 
153,000,000 4,3
 
(2,581,000,000) 
 
1,312,900,000  
 
1,281,600,000  
 
262,900,000  
 
881,100,000  
 
172,600,000  
 
1,330,100,000  
 
270,200,000 4,3
 
(1,724,500,000) 
 
1,275,800,000  
 
1,289,900,000  
 
0  
 
409,300,000  
 
28,000,000  
 
1,278,500,000  
 
Less: Net income attributable to non-controlling interest
4,100,000 3
11,400,000 3
7,500,000 3
0  
0  
0  
0  
0  
28,100,000  
28,100,000  
5,100,000 3
6,900,000 3
4,500,000 3
3,400,000 4,3
0  
0  
0  
0  
0  
17,200,000  
17,200,000  
2,400,000 4,3
0  
0  
0  
0  
0  
2,700,000  
2,700,000  
Net income attributable to Express Scripts
501,900,000 3
426,700,000 3
543,000,000 3
(3,140,100,000) 
1,844,600,000  
1,669,100,000  
394,600,000  
820,600,000  
255,800,000  
1,844,600,000  
373,000,000 3
504,100,000 3
391,400,000 3
149,600,000 4,3
(2,581,000,000) 
1,312,900,000  
1,281,600,000  
262,900,000  
881,100,000  
155,400,000  
1,312,900,000  
267,800,000 4,3
(1,724,500,000) 
1,275,800,000  
1,289,900,000  
0  
409,300,000  
25,300,000  
1,275,800,000  
Other comprehensive income (loss), net of tax
 
 
 
14,400,000  
(7,200,000) 
(7,200,000) 
0  
0  
(7,200,000) 
(7,200,000) 
 
 
 
 
(3,800,000) 
1,900,000  
1,900,000  
0  
0  
1,900,000  
1,900,000  
 
5,600,000  
(2,800,000) 
(2,800,000) 
0  
0  
(2,800,000) 
(2,800,000) 
Comprehensive income attributable to Express Scripts
 
 
 
(3,125,700,000) 
1,837,400,000  
1,661,900,000  
394,600,000  
820,600,000  
248,600,000  
1,837,400,000  
 
 
 
 
(2,584,800,000) 
1,314,800,000  
1,283,500,000  
262,900,000  
881,100,000  
157,300,000  
1,314,800,000  
 
(1,718,900,000) 
1,273,000,000  
1,287,100,000  
0  
409,300,000  
22,500,000  
1,273,000,000  
1: Includes retail pharmacy co-payments of $12,620.3, $11,668.6 and $5,786.6 for the years ended December 31, 2013, 2012 and 2011, respectively.
2: Includes retail pharmacy co-payments of $3,674.4 and $1,496.6 for the three months ended March 31, 2013 and 2012, respectively, $3,204.3 and $3,519.1 for the three months ended June 30, 2013 and 2012, respectively, $2,966.5 and $3,348.9 for the three months ended September 30, 2013 and 2012, respectively, and $2,775.1 and $3,304.0 for the three months ended December 31, 2013 and 2012, respectively.
3: Adjusted to reflect the results of our acute infusion therapies line of business as discontinued.
4: Includes the April 2, 2012 acquisition of Medco.